Abstract:

The pharmaceutical industry is one of the biggest investors in research and innovation. Most countries have controlled the trade and patent of pharma products. Under the control of Trade-Related Aspects of Intellectual Property Rights (TRIPS) (1994), many countries have controlled their patent protection for pharma products. This is used to induce investment in clinical trials and innovations. Most of the pharma product’s production process can easily be duplicated with fewer investments than that of original brand-name products.  After patent exclusivity expires, generic producers will face intense competition in the market, which may or may not lead to lower prices, making safe access to essential medicines more difficult. Our government introduced the generic drugs which are approved by Food and Drug Administration (FDA) in (i) dosage, (ii) concentration, (iii), safety and, (iv)route of administration must be comparable to the parent drug (the drug described in the reference). v) quality, vi) results and vii) utility. Generic medicines were formulated in different countries at many times, from 1984 in USA and 1996 in Italy. Generic medicines are gaining increasing interest from many stakeholders because they allow patients to have similar treatment at a lesser price. At the same time, the research shows that the progress of this market is deliberate. Against these conditions, research on customer buying behavior for generic drugs has been used by health policy-makers and business leaders, mainly in countries such as India and Brazil, where regulations boost the manufacture and sale of generic drugs. This research will review those studies which will throw light on the purchase intentions and attitudes towards generic medicines in Tamil Nadu.

References:

[1].   Jain, S., 2022, Knowledge, Attitude, and Practice of Generic Medicines Among Consumers in India. Journal of Health Management, 24(1), 55-66.

[2].   Rao, P., 2021. Consumer Behavior Towards Generic Medicines in Tamil Nadu. Indian Journal of Pharmaceutical Sciences, 83(4), 425-433.

[3].   Sims, S., Kantipudi, S. J., Ashok, Y., et al. 2024. Effectiveness of virtual-compensatory cognitive training (V-CCT) for improving cognition in persons with schizophrenia: A multi-centre randomized controlled trial. Trials, 25, 736.

[4].   Arunkumar, R., Venkatesa Palanichamy, N., Rohini, A., and Nirmala Devi, M., 2021. A study on customer buying pattern of generic medicines from Jan Aushadhi medical stores in Coimbatore city of Tamil Nadu, The Pharma Innovation Journal, SP-10(10), 01-05.

[5].   Mohan, R., 2023. Research on Generic Medicine Acceptance: A Tamil Nadu Case Study. Health Economics and Outcomes Research, 15(2), 211-220.

[6].   Raj, K., 2022. Enhancing the Acceptance of Generic Medicines. Journal of Healthcare Management, 17(4), 362-370.

[7].   Anushree Mishra, Delivering medicines access for all: The Tamil Nadu model for state drug procurement.

[8].   Basak, S. C., and Sathyanarayana, D., 2012. Exploring knowledge and perceptions of generic medicines among drug retailers and community pharmacists, Indian Journal of Pharmaceutical Sciences, Doi: 10.4103/0250-474X.110611.

[9].   Venkatesa Palanichamy, N., Santhosh Kumar, M., Kalpana, M., Balakrishnan, N., Rajavel M., and Divya, M., 2024., A Review on Consumer Patterns and Behaviours’ Towards Generic Medicines, Advances in Research, 25(4), Page 456-464. Doi:10.9734/air/2024/v25i41125

[10].  Sanjiv Kumar, Promotion of Generic Medicines: Laudable Efforts But Must Engage all Stakeholders.

[11].  Tamil Nadu State Health Policy Vision, 2030.

[12].  Mudhalvar Marunthagam to cut back on soaring medical bills https://www.dtnext.in/news/tamilnadu/mudhalvar-marunthagam-to-cut-back-on-soaring-medical-bills-803728?form=MG0AV3

[13].  Biju, A. K., B. N., & Shanmugam, R. 2024. A thorough examination of Peltophorum pterocarpum phytochemicals in network pharmacology-based management of acne vulgaris. Cureus, 16(8), e68159.

[14].  Gowri Parvathy, S. R., Sowparnika Treasa Sabu, and Shaiju Dharan, S., 2020. Insights on Patient Perception towards Generic vs Branded drugs, World Journal of Pharmaceutical Research, 9(11), 840-851.

[15].  Ankit Pandey, Shivangi Singh, Vaishali Yadav, Jhalki Sagar, Alok Verma, 2024, Understanding Doctors and Pharmacist Perspective on Generic Medicine, International Journal of Pharmacy and Pharmaceutical Research, 30(5), 1-14.

[16].  Yaser Mohammed Al-Worafi, 2023, Generic Medicines’ Knowledge, Attitude, Practice, and Acceptance by Patients and Healthcare Professionals.

[17].  Nisha, B., Gopal, S., Venkatasubramanian, P., Durairaj, J., Ashok, Y., Joseph, E., Ramachandran, P. 2025.Predictors of user engagement in online psychosocial interventions for schizophrenia in Chennai, India. Indian Journal of Psychiatry, 67, S208.

[18].  Ricardo Arcaro, Cássia Rita Pereira da Veiga, Wesley Vieira da Silva and Claudimar Pereira da Veiga, 2021, Attitude and Purchase Intention to Generic Drugs, International Journal of Environmental Research and Public Health, 18(9), https://doi.org/10.3390/ijerph18094579

[19].  Patel, A., 2019. Economic Influences on the Acceptance of Generic Medicines. Journal of Public Health Policy, 40(3), 345-354.

[20].  Kumar, V., 2020. The Impact of Government Initiatives on Generic Medicine Usage. Health Policy and Planning, 35(5), 489-497.